Edwards Lifesciences Provides Earnings Guidance for the First Quarter and Full Year of 2022
For the full year, the company expects sales grow at a low double-digit rate to $5.5 billion to $6.0 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.78 USD | +1.18% | +1.62% | +16.26% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 17 | Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 | MT |
1st Jan change | Capi. | |
---|---|---|
+16.26% | 52.82B | |
+8.20% | 219B | |
+8.15% | 187B | |
+11.10% | 134B | |
+26.87% | 101B | |
+0.30% | 62.27B | |
-1.63% | 47.49B | |
-1.13% | 40.79B | |
+12.53% | 39.35B | |
+7.38% | 27.06B |